Skip to main navigation Skip to search Skip to main content

An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

  • C.M. Sanders
  • , C.A. Langley
  • , J. Persaud
  • , J.F. Marriott
  • , K.A. Wilson
  • Aston University
  • Birmingham Women's NHS Foundation Trust

Research output: Contribution to journal › Conference abstract › peer-review

Abstract

Poster session
- Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form
- It is not uncommon for alcohol to be present in liquid preparations, often as a solvent
- Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity
- It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol
- The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination
Original languageEnglish
Pages (from-to)R37
Number of pages1
JournalInternational Journal of Pharmacy Practice
Volume11
Issue numberS1
DOIs
Publication statusPublished - Sept 2003
EventBritish Pharmaceutical Conference 2003 - Harrogate, United Kingdom
Duration: 15 Sept 2003 → 17 Sept 2003

Fingerprint

Dive into the research topics of 'An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients'. Together they form a unique fingerprint.

Cite this